Sign Up to like & get
recommendations!
0
Published in 2019 at "American Journal of Transplantation"
DOI: 10.1111/ajt.15613
Abstract: Proteasome inhibitor–based strategies hold promise in transplant but have yielded varying results. Carfilzomib, a second‐generation proteasome inhibitor, may possess advantages over bortezomib, the first‐generation proteasome inhibitors. The purpose of this study was to evaluate the…
read more here.
Keywords:
adaptive trial;
iterative adaptive;
based desensitization;
desensitization ... See more keywords